CVE-2024-52378 Vulnerability Details

  /     /     /  

CVE-2024-52378 Metadata Quick Info

CVE Published: 14/11/2024 | CVE Updated: 18/11/2024 | CVE Year: 2024
Source: Patchstack | Vendor: Labs64 | Product: DigiPass
Status : PUBLISHED

---

CVE-2024-52378 Description

Improper Limitation of a Pathname to a Restricted Directory (\'Path Traversal\') vulnerability in Labs64 DigiPass allows Absolute Path Traversal.This issue affects DigiPass: from n/a through 0.3.0.

Metrics

CVSS Version: 3.1 | Base Score: 7.5 HIGH
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

l➤ Exploitability Metrics:
    Attack Vector (AV)* NETWORK
    Attack Complexity (AC)* LOW
    Privileges Required (PR)* NONE
    User Interaction (UI)* NONE
    Scope (S)* UNCHANGED

l➤ Impact Metrics:
    Confidentiality Impact (C)* HIGH
    Integrity Impact (I)* NONE
    Availability Impact (A)* NONE

Weakness Enumeration (CWE)

CWE-ID: CWE-22
CWE Name: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ( Path Traversal )
Source: Labs64

Common Attack Pattern Enumeration and Classification (CAPEC)

CAPEC-ID: CAPEC-597
CAPEC Description: CAPEC-597 Absolute Path Traversal